SILK ROAD MEDICAL INC (SILK)
US82710M1009 - Common Stock
ChartMill assigns a Buy % Consensus number of 49% to SILK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.54. This target is -18% below the current price.
SILK was analyzed by 13 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about SILK.
In the previous month the buy percentage consensus was at a similar level.
SILK was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-17 | Stifel | Downgrade | Buy -> Hold |
| 2024-07-11 | Argus Research | Downgrade | Buy -> Sell |
| 2024-06-18 | Lake Street | Downgrade | Buy -> Hold |
| 2024-05-01 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-05-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-03-07 | Argus Research | Upgrade | Hold -> Buy |
| 2024-02-29 | Stifel | Maintains | Buy -> Buy |
| 2024-02-29 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-29 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-01-19 | Stifel | Upgrade | Hold -> Buy |
| 2024-01-03 | Lake Street | Initiate | Buy |
| 2023-10-24 | Wolfe Research | Upgrade | Underperform -> Peer Perform |
| 2023-10-11 | CL King | Downgrade | Buy -> Neutral |
| 2023-10-11 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2023-10-11 | Stifel | Downgrade | Buy -> Hold |
| 2023-10-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-10-11 | Citigroup | Downgrade | Buy -> Sell |
| 2023-09-21 | Argus Research | Downgrade | Buy -> Hold |
| 2023-09-06 | Oppenheimer | Initiate | Outperform |
| 2023-08-14 | Citigroup | Maintains | Buy -> Buy |
| 2023-08-02 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-08-02 | Stifel | Maintains | Buy -> Buy |
| 2023-07-12 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-07-12 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-07-11 | Citigroup | Reiterate | Buy -> Buy |
| 2023-05-23 | CL King | Initiate | Buy |
| 2023-05-22 | Argus Research | Maintains | Buy -> Buy |
| 2023-05-15 | Wolfe Research | Downgrade | Peer Perform -> Underperform |
| 2023-05-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-05-10 | Citigroup | Maintains | Buy |